JP2001031587A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001031587A5 JP2001031587A5 JP2000159149A JP2000159149A JP2001031587A5 JP 2001031587 A5 JP2001031587 A5 JP 2001031587A5 JP 2000159149 A JP2000159149 A JP 2000159149A JP 2000159149 A JP2000159149 A JP 2000159149A JP 2001031587 A5 JP2001031587 A5 JP 2001031587A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- ehv4
- vivo
- acid encoding
- thymidine kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99400964A EP1046400B1 (en) | 1999-04-20 | 1999-04-20 | Use of an Equine herpes virus type-4 thymidine kinase and a nucleoside analog selected from ganciclovir and acyclovir for the killing of human proliferative cells |
EP99400964.5 | 1999-04-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001031587A JP2001031587A (ja) | 2001-02-06 |
JP2001031587A5 true JP2001031587A5 (ko) | 2007-05-31 |
Family
ID=8241950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000159149A Pending JP2001031587A (ja) | 1999-04-20 | 2000-04-20 | ヒト細胞を処理するための方法及び組成物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1046400B1 (ko) |
JP (1) | JP2001031587A (ko) |
AT (1) | ATE298245T1 (ko) |
CA (1) | CA2306355A1 (ko) |
DE (1) | DE69925894T2 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5757608B2 (ja) * | 2009-11-18 | 2015-07-29 | 国立大学法人 千葉大学 | 遺伝子スイッチおよび遺伝子回路の選択方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9014951D0 (en) * | 1990-07-06 | 1990-08-29 | Univ Glasgow | Equine herpesvirus-4 tk vaccine |
FR2716459B1 (fr) * | 1994-02-22 | 1996-05-10 | Univ Paris Curie | Système hôte-vecteur utilisable en thérapie génique. |
-
1999
- 1999-04-20 DE DE69925894T patent/DE69925894T2/de not_active Expired - Lifetime
- 1999-04-20 EP EP99400964A patent/EP1046400B1/en not_active Expired - Lifetime
- 1999-04-20 AT AT99400964T patent/ATE298245T1/de not_active IP Right Cessation
-
2000
- 2000-04-19 CA CA002306355A patent/CA2306355A1/en not_active Abandoned
- 2000-04-20 JP JP2000159149A patent/JP2001031587A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mattson et al. | Brain injury and tumor necrosis factors induce calbindin D‐28k in astrocytes: evidence for a cytoprotective response | |
Chandler et al. | Matrix‐enabled gene transfer for cutaneous wound repair | |
US6811774B2 (en) | Defective recombinant adenoviruses expressing cytokines for antitumor treatment | |
RU2001117230A (ru) | Пептиды, ингибирующие трансформирующий фактор роста tgf$$$1 | |
SI1496944T1 (sl) | Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov | |
PT1062321E (pt) | Utilizacoes para celulas estaminais mesenquimais humanas nao autologas | |
JP2003527064A5 (ko) | ||
ATE192500T1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
DE69914932D1 (de) | Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis | |
CA2100553A1 (en) | Treatment of neoplastic disease with interleukin-10 | |
DE602005024805D1 (de) | Adenovirus/alphavirus-hybrid-vektor zur effektiven verabreichung und expression von therapeutischen genen in tumorzellen | |
JP2002503642A5 (ko) | ||
JP2004501650A5 (ko) | ||
JP2003528138A5 (ko) | ||
JP2001031587A5 (ko) | ||
JPH0971542A (ja) | 遺伝子製剤 | |
ES2372728T3 (es) | Cicatrización de heridas mediante la administración de il-18 humana. | |
KR100431779B1 (ko) | 유전자제제 | |
KR970706397A (ko) | IV a2 유전자가 불활성화된 결손 재조합 아데노바이러스(DEFECTIVE RECOMBINANT ADENOVIRUSES WITH AN INACTIVATED IV a2 GENE) | |
HK1002284A1 (en) | Novel implant and novel vector for the treatment of acquired diseases | |
BR9812138A (pt) | Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta | |
KR20010043764A (ko) | 안정한 유전자 제제 | |
JP2003189887A5 (ko) | ||
WO2000006735A8 (en) | Interferon alpha hybrids | |
Evans et al. | Arthritis |